Comments*

 
  • Life Sciences & Biomedical Research

  • Past Events

    Thursday, November 2, 2017 | 9:00 AM - 5:00 PM

    Mitochondria in Health and Disease

    Speakers: Marcia Haigis (Harvard Medical School), Vamsi Mootha (Harvard Medical School), Andrew Dillin (UC Berkeley), Adam Hughes (University of Utah School of Medicine), Jahar Bhattacharya (Columbia University Irving Medical Center), Jodi Nunnari (University of California, Davis), Navdeep S. Chandel (Northwestern University), J. Wade Harper (Harvard Medical School), and David J. Glass (Novartis Institutes for Biomedical Research)

    This symposium will bring together cross-disciplinary researchers to explore mitochondrial biology, the role played by mitochondria in disease, and their potential as a therapeutic target.

    Monday, June 19, 2017 | 1:30 PM - 6:00 PM

    Genome Integrity Discussion Group

    Keynote Speaker: Stephen J. Elledge (Harvard Medical School)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    June 13 - 14, 2017

    Neuroplasticity, Neuroregeneration, and Brain Repair

    Keynote Speaker: Michael V. Sofroniew (David Geffen School of Medicine at UCLA)

    The conference will explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries.

    Monday, June 5, 2017 | 12:30 PM - 5:30 PM

    2017 Ross Prize in Molecular Medicine — Regulating Immunity: Fc Receptor Biology

    Featuring: Jeffrey V. Ravetch (The Rockefeller University)

    The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine.

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

    Tuesday, April 25, 2017 | 9:00 AM - 5:00 PM

    Complement Pathways in Disease

    Keynote Speaker: V. Michael Holers (University of Colorado School of Medicine)

    The complement system is the first line of defense against infection, however we have yet to capitalize on its therapeutic potential. This symposium will focus on novel insights into the complement pathway in a number of clinical disorders.

    Tuesday, April 11, 2017 | 9:00 AM - 5:00 PM

    Gene Therapy for Rare Diseases

    Speakers: Brian Kaspar (AveXis Inc.), R. Jude Samulski (Bamboo Therapeutics), Barry Byrne (University of Florida Powell Gene Therapy Center), Maria Escolar (University of Pittsburgh), Jakub Tolar (University of Minnesota), Kevin Flanigan (Nationwide Children's Hospital), Katherine A. High (Spark Therapeutics), and Steven J. Gray (University of North Carolina at Chapel Hill)

    Gene therapy has been proposed as a promising therapeutic strategy for monogenic disorders. This symposium will explore recent advances in the field, and identify ongoing obstacles on the path to wider use of this approach.

    Monday, April 10, 2017 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Hironori Funabiki (The Rockefeller University), Tony Huang (NYU School of Medicine), Amy MacQueen (Wesleyan University), and Jessica Tyler (Weill Cornell Medical College)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, March 21, 2017 | 12:00 PM - 5:00 PM

    Exosomes in the CNS

    Speakers: Tsuneya Ikezu (Boston University School of Medicine), David Issadore (University of Pennsylvania), Xandra Breakefield (Massachusetts General Hospital), Efrat Levy (NYU School of Medicine), Robert A. Rissman (University of California San Diego, School of Medicine), and Andrew West (The University of Alabama at Birmingham)

    In this symposium we will explore the contribution of extracellular vesicles to pathological processes underlying neurodegenerative disorders, and the appeal of exosomes as biomarkers and targets for the development of novel therapeutics.

    Monday, March 13, 2017 | 9:00 AM - 4:45 PM

    Targeting Tau in Alzheimer's Disease and Related Disorders

    Speakers: Michael G. Agadjanyan (The Institute for Molecular Medicine), Bernardino Ghetti (Indiana University School of Medicine), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Viktoriya Morozova (College of Staten Island, The City University of New York), Einar M. Sigurdsson (New York University School of Medicine), Qian Wu (New York University School of Medicine), Emanuele Sher (Lilly UK), and Henrik Zetterberg (University of Gothenburg, Sweden)

    This event will cover the translational potential of immunotherapy for tauopathies, reviewing the pre-clinical and clinical development of several tau immunotherapy programs that exemplify this emerging therapeutic approach.